Pharmacogenomics and perioperative medicine--implications for modern clinical practice.
Kim
Jerry H
JH
Schwinn
Debra A
DA
Landau
Ruth
R
D000318:Adrenergic beta-Agonists / Q000493:pharmacokinetics; D000319:Adrenergic beta-Antagonists / Q000493:pharmacokinetics; D016362:Analgesia, Obstetrical / Q000379:methods; D000701:Analgesics, Opioid / Q000493:pharmacokinetics; D000776:Anesthesiology / Q000379:methods*; D018681:Anesthetics, General / Q000493:pharmacokinetics; D000925:Anticoagulants / Q000493:pharmacokinetics; D001249:Asthma / Q000235:genetics / Q000378:metabolism; D064420:Drug-Related Side Effects and Adverse Reactions / Q000378:metabolism / Q000517:prevention & control; D014644:Genetic Variation; D006801:Humans; D008305:Malignant Hyperthermia / Q000235:genetics / Q000378:metabolism; D009203:Myocardial Infarction / Q000235:genetics / Q000378:metabolism; D009467:Neuromuscular Depolarizing Agents / Q000493:pharmacokinetics; D010149:Postoperative Pain / Q000235:genetics / Q000378:metabolism; D019990:Perioperative Care; D010597:Pharmacogenetics; D010818:Practice Patterns, Physicians'; D013390:Succinylcholine / Q000493:pharmacokinetics; D014859:Warfarin / Q000493:pharmacokinetics
D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D000701:Analgesics, Opioid; D018681:Anesthetics, General; D000925:Anticoagulants; D009467:Neuromuscular Depolarizing Agents; D014859:Warfarin; D013390:Succinylcholine